B. Hanzelka

发表

Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis

Tara L. Kieffer, H. Chu, A. Kwong, 2009 .

Acyl homoserine-lactone quorum-sensing signal generation.

E. Greenberg, J. Cronan, M. Parsek, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Evidence that the N-terminal region of the Vibrio fischeri LuxR protein constitutes an autoinducer-binding domain

E. Greenberg, B. Hanzelka, E P Greenberg, 1995, Journal of bacteriology.

Quorum sensing in Vibrio fischeri: evidence that S-adenosylmethionine is the amino acid substrate for autoinducer synthesis

E. Greenberg, B. Hanzelka, E P Greenberg, 1996, Journal of bacteriology.

Mutational analysis of the Vibrio fischeri LuxI polypeptide: critical regions of an autoinducer synthase

E. Greenberg, M. Parsek, A. Stevens, 1997, Journal of bacteriology.

In Vitro Phenotypic Characterization of Hepatitis C Virus NS3 Protease Variants Observed in Clinical Studies of Telaprevir

Tara L. Kieffer, B. G. Rao, O. Nicolas, 2013, Antimicrobial Agents and Chemotherapy.

Observed in Clinical Studies of Telaprevir Hepatitis C Virus NS3 Protease Variants Phenotypic Characterization of In Vitro

Tara L. Kieffer, B. G. Rao, O. Nicolas, 2013 .

TFE, an Archaeal Transcription Factor in Methanobacterium thermoautotrophicum Related to Eucaryal Transcription Factor TFIIEα

J. Reeve, B. Hanzelka, T. J. Darcy, 2001, Journal of bacteriology.

Phenotypic and Structural Analyses of Hepatitis C Virus NS3 Protease Arg155 Variants

A. Kwong, B. G. Rao, L. Swenson, 2007, Journal of Biological Chemistry.

Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir.

Tara L. Kieffer, H. Chu, A. Kwong, 2007, Gastroenterology.

PHENOTYPIC AND STRUCTURAL ANALYSES OF HCV NS3 PROTEASE ARG 155 VARIANTS: SENSITIVITY TO TELAPREVIR (VX-950) AND INTERFERON ALPHA

A. Kwong, B. G. Rao, L. Swenson, 2007 .

Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions.

G. Bemis, Tiansheng Wang, B. Hanzelka, 2017, ACS medicinal chemistry letters.

Discovery and Characterization of a Water-Soluble Prodrug of a Dual Inhibitor of Bacterial DNA Gyrase and Topoisomerase IV.

P. Charifson, D. Nicolau, B. Hanzelka, 2015, ACS medicinal chemistry letters.

High in vitro activity of a novel dual bacterial topoisomerase inhibitor of the ATPase activities of GyrB and ParE (VT12-008911) against Neisseria gonorrhoeae isolates with various high-level antimicrobial resistance and multidrug resistance.

M. Unemo, B. Hanzelka, D. Golparian, 2014, The Journal of antimicrobial chemotherapy.

Detection, purification, and structural elucidation of the acylhomoserine lactone inducer of Vibrio fischeri luminescence and other related molecules.

E. Greenberg, M. Parsek, B. Hanzelka, 2000, Methods in enzymology.

Phenotypic Characterization of Resistant Val36 Variants of Hepatitis C Virus NS3-4A Serine Protease

H. Chu, A. Kwong, B. G. Rao, 2007, Antimicrobial Agents and Chemotherapy.

12 Wild-type HCV NS3 protease re-emerges during follow-up after 14 days of dosing with VX-950 in patients with genotype 1 HCV

A. Kwong, S. Zeuzem, C. Sarrazin, 2006 .

Quorum sensing in Vibrio fischeri: probing autoinducer-LuxR interactions with autoinducer analogs

E. Greenberg, A. Eberhard, B. Hanzelka, 1996, Journal of bacteriology.

Generation of cell-to-cell signals in quorum sensing: acyl homoserine lactone synthase activity of a purified Vibrio fischeri LuxI protein.

E. Greenberg, J. Cronan, B. Hanzelka, 1996, Proceedings of the National Academy of Sciences of the United States of America.

A structurally unrelated mimic of a Pseudomonas aeruginosa acyl-homoserine lactone quorum-sensing signal

E. Greenberg, R. Heim, M. Schuster, 2006, Proceedings of the National Academy of Sciences.

J. Reeve, B. Hanzelka, T. J. Darcy, 2001 .

In Vitro Characterization of the Antibacterial Spectrum of Novel Bacterial Type II Topoisomerase Inhibitors of the Aminobenzimidazole Class

P. Charifson, T. Grossman, C. H. Gross, 2006, Antimicrobial Agents and Chemotherapy.

Second-generation antibacterial benzimidazole ureas: discovery of a preclinical candidate with reduced metabolic liability.

P. Charifson, T. Grossman, Tiansheng Wang, 2014, Journal of medicinal chemistry.

A Novel Inhibitor of Gyrase B Is a Potent Drug Candidate for Treatment of Tuberculosis and Nontuberculosis Mycobacterial Infections

P. V. van Helden, M. Cynamon, E. Perola, 2014, Antimicrobial Agents and Chemotherapy.

Phenotypic Characterization of Resistant Val 36 Variants of Hepatitis C Virus NS3-4A Serine Protease (cid:1)

H. Chu, A. Kwong, B. G. Rao, 2007 .

Acylhomoserine Lactone Synthase Activity of the Vibrio fischeri AinS Protein

P. Dunlap, E. Greenberg, J. Cronan, 1999, Journal of bacteriology.

[12] TELAPREVIR (VX-950) IS A POTENT INHIBITOR OF HCV NS3 PROTEASES DERIVED FROM GENOTYPE NON-1 HCV-INFECTED PATIENTS

A. Kwong, D. Bartels, B. Hanzelka, 2007 .